Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy. | Genes (Basel) | 2022 | 35205250 | PubTator, text mining | PubMed |
| CRISPR/Cas9-induced gene conversion between ATAD3 paralogs. | HGG Adv | 2022 | 35199044 | PubTator, text mining | PubMed |
| [Interfering RNA and antisense oligonucleotide treatments currently available in France: An update]. | Bull Acad Natl Med | 2022 | 35194225 | PubTator, text mining | PubMed |
| Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy. | Ann Clin Transl Neurol | 2022 | 35191616 | PubTator, text mining | PubMed |
| The molecular characteristics of low-grade and high-grade areas in desmoplastic infantile astrocytoma/ganglioglioma. | Neuropathol Appl Neurobiol | 2022 | 35191090 | PubTator, text mining | PubMed |
| Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study. | Orphanet J Rare Dis | 2022 | 35189949 | PubTator, text mining | PubMed |
| Spinal Muscular Atrophy Type IIIb Complicated by Moyamoya Syndrome: A Case Report and Literature Review. | Front Cell Neurosci | 2022 | 35177965 | PubTator, text mining | PubMed |
| Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy. | Ann Clin Transl Neurol | 2022 | 35170254 | PubTator, text mining | PubMed |
| 5'RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa. | Int J Mol Sci | 2022 | 35163654 | PubTator, text mining | PubMed |
| The Multifunctional Faces of T-Cell Intracellular Antigen 1 in Health and Disease. | Int J Mol Sci | 2022 | 35163320 | PubTator, text mining | PubMed |
| Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy. | Cells | 2022 | 35159369 | PubTator, text mining | PubMed |
| Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy. | Cells | 2022 | 35159227 | PubTator, text mining | PubMed |
| Spinal muscular atrophy type 2 patient who survived 61 years: an autopsy case report. | Neuropathology | 2022 | 35144320 | PubTator, text mining | PubMed |
| Single-Tube Multiplex Digital Polymerase Chain Reaction Assay for Molecular Diagnosis and Prediction of Severity of Spinal Muscular Atrophy. | Anal Chem | 2022 | 35137581 | PubTator, text mining | PubMed |
| Curated variation benchmarks for challenging medically relevant autosomal genes. | Nat Biotechnol | 2022 | 35132260 | PubTator, text mining | PubMed |
| Patients' access to rare neuromuscular disease therapies varies across US private insurers. | Orphanet J Rare Dis | 2022 | 35123543 | PubTator, text mining | PubMed |
| Newborn screening for spinal muscular atrophy: The Wisconsin first year experience. | Neuromuscul Disord | 2022 | 35120759 | PubTator, text mining | PubMed |
| Evolution of bulbar function in spinal muscular atrophy type 1 treated with nusinersen. | Dev Med Child Neurol | 2022 | 35103306 | PubTator, text mining | PubMed |
| Viral mediated knockdown of GATA6 in SMA iPSC-derived astrocytes prevents motor neuron loss and microglial activation. | Glia | 2022 | 35088910 | PubTator, text mining | PubMed |
| Heat increases full-length SMN splicing: promise for splice-augmenting therapies for SMA. | Hum Genet | 2022 | 35088120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=52